Predictive Factors for Return to Work After a First Stroke Treated at Clermont-Ferrand University Hospital in Puy de Dôme Between January 2020 and December 2024
NCT ID: NCT07264387
Last Updated: 2025-12-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
140 participants
OBSERVATIONAL
2025-10-29
2026-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Needs Assessment and Quality of Life of Stroke Patients and Their Caregivers
NCT03217279
Brain Plasticity Mapping Post-stroke
NCT03223571
Evaluation of the Improvement of Independence by the Resumption of a Significant Activity Such as a Cooking Workshop in Adult Patients With Stroke Benefiting From Traditional Rehabilitation
NCT03274843
Evaluation of the Benefit of the Training of the Manual Dexterity Post Stroke.
NCT03934073
Post-stroke Pathway: Analysis and Link With One Year Sequelae in a French Cohort of Stroke Patients
NCT03865173
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients of working age/under 64 years of age (legal retirement age)
* Patients with an employment contract at the time of the stroke
* Patients treated at Clermont-Ferrand University Hospital
* Post-stroke consultation recorded in the patient's medical file
* Patients affiliated with the social security system
* Patients who have not objected to participating in the study
Exclusion Criteria
* Patients with a history of head trauma with neurological sequelae corresponding to codes S060, S061, S062, S063, S065, S066, S067, S068 and S069
* Patients who died as a result of stroke
* Patients unable to respond to telephone questionnaires
* Patients under guardianship or trusteeship
* Patients who have suffered a transient ischaemic attack (TIA) (G459 according to ICD 10)
* Patients who were in early retirement at the time of assessment
* No information on employment after stroke in the medical file
* Patients with category 2 or 3 disability prior to stroke due to another condition
* Patients on sick leave prior to stroke due to another condition
* Patients receiving RSA income support
18 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lise Laclautre
Role: STUDY_DIRECTOR
University Hospital, Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clermont Ferrand University Hospital, Louise Michel site
Cébazat, France, France
CHU Clermont-Ferrand, Louise Michel
Clermont-Ferrand, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RNI 2025 ORANGE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.